Year archive

Nykode Therapeutics ASA — 2024 filings

All 69 regulatory filings released by Nykode Therapeutics ASA (NYKD) in 2024, sourced directly from the official regulator.

69 Filings

2024 Period

2024 filings (69)

Filing	Released	Lang
Nykode Therapeutics - Quarterly report Q3 2024 Interim / Quarterly Report Q3 2024	2024-11-26	English
Nykode Therapeutics - Quarterly report Q3 2024 Report Publication Announcement	2024-11-26	English
Nykode Therapeutics – invitation to Q3 2024 financial results presentation Report Publication Announcement	2024-11-20	English
Nykode Therapeutics – invitation to Q3 2024 financial results presentation Earnings Release Q3 2024	2024-11-20	English
Nykode Therapeutics ASA - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider Director's Dealing	2024-11-08	English
Nykode Therapeutics ASA - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider Director's Dealing	2024-11-08	English
Disclosure of large shareholding in Nykode Therapeutics ASA Major Shareholding Notification	2024-11-08	English
Nykode Therapeutics – Webcast Invitation Regulatory Filings	2024-11-07	English
Nykode Therapeutics – Webcast Invitation Report Publication Announcement	2024-11-07	English
Nykode Therapeutics to Regain Control of VB10.NEO Program Regulatory Filings	2024-11-07	English
Nykode Therapeutics to Regain Control of VB10.NEO Program Regulatory Filings	2024-11-07	English
Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at PEGS Europe Regulatory Filings	2024-11-06	English
Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at PEGS Europe Regulatory Filings	2024-11-06	English
Major shareholding notification Major Shareholding Notification	2024-09-27	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-08-21	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-08-21	English
Nykode Therapeutics - Quarterly report Q2 2024 Interim / Quarterly Report Q2 2024	2024-08-21	English
Nykode Therapeutics - Quarterly report Q2 2024 Report Publication Announcement Q2 2024	2024-08-21	English
Nykode Therapeutics Announces Strategic Repositioning of VB10.16 to Focus on Locally Advanced Cervical Cancer and Recurrent Metastatic Head and Neck Cancer Regulatory Filings	2024-08-21	English
Nykode Therapeutics Announces Strategic Repositioning of VB10.16 to Focus on Locally Advanced Cervical Cancer and Recurrent Metastatic Head and Neck Cancer Regulatory Filings	2024-08-21	English
Nykode Therapeutics Announces Issuance of Key Patent Covering Individualized Neoantigen Based Vaccines Regulatory Filings	2024-08-14	English
Nykode Therapeutics Announces Issuance of Key Patent Covering Individualized Neoantigen Based Vaccines Regulatory Filings	2024-08-14	English
Nykode Therapeutics – invitation to Q2 2024 financial results presentation Earnings Release Q2 2024	2024-08-01	English
Nykode Therapeutics – invitation to Q2 2024 financial results presentation Report Publication Announcement	2024-08-01	English
Nykode Therapeutics - Grant of share options Director's Dealing	2024-07-01	English
Nykode Therapeutics - Grant of share options Remuneration Information	2024-07-01	English
Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting Regulatory Filings	2024-06-20	English
Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting Regulatory Filings	2024-06-20	English
Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy Regulatory Filings	2024-06-11	English
Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy Investor Presentation	2024-06-11	English
Nykode Therapeutics - Grant of share options Director's Dealing	2024-05-24	English
Nykode Therapeutics - Grant of share options Share Issue/Capital Change	2024-05-24	English
Nykode Therapeutics ASA - Minutes of Annual General Meeting AGM Information	2024-05-16	English
Nykode Therapeutics ASA - Minutes of Annual General Meeting AGM Information	2024-05-16	English
Nykode Therapeutics - Quarterly report Q1 2024 Interim / Quarterly Report Q1 2024	2024-05-14	English
Nykode Therapeutics - Quarterly report Q1 2024 Report Publication Announcement	2024-05-14	English
Nykode Therapeutics – invitation to Q1 2024 financial results presentation Report Publication Announcement	2024-05-07	English
Nykode Therapeutics – invitation to Q1 2024 financial results presentation Report Publication Announcement	2024-05-07	English
Nykode Therapeutics ASA - Notice of Annual General Meeting AGM Information	2024-04-25	Norwegian
Nykode Therapeutics ASA - Notice of Annual General Meeting AGM Information	2024-04-25	Norwegian
Nykode Therapeutics ASA - Notice of Annual General Meeting AGM Information	2024-04-25	English
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer Regulatory Filings	2024-04-19	English
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer Regulatory Filings	2024-04-19	English
Nykode Therapeutics - Annual Report 2023 Environmental & Social Information	2024-04-19	English
Nykode Therapeutics - Annual Report 2023 Annual Report FY 2023	2024-04-19	English
Nykode Therapeutics - Annual Report 2023 Annual Report FY 2023	2024-04-19	English
Nykode Therapeutics - Annual Report 2023 Report Publication Announcement	2024-04-19	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-26	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-26	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-21	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-21	English
Nykode Therapeutics Announces Topline Conclusions Affirming Prolonged Clinical Benefits from Matured Survival Data in Phase 2 C-02 Trial in Advanced Cervical Cancer Regulatory Filings	2024-03-21	English
Nykode Therapeutics Announces Topline Conclusions Affirming Prolonged Clinical Benefits from Matured Survival Data in Phase 2 C-02 Trial in Advanced Cervical Cancer Regulatory Filings	2024-03-21	English
Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases Regulatory Filings	2024-03-19	English
Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases Regulatory Filings	2024-03-19	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-13	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-13	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-08	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-08	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-08	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Major Shareholding Notification	2024-03-08	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-04	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-03-04	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-02-29	English
Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider Director's Dealing	2024-02-29	English
Nykode Therapeutics - Quarterly report Q4 2023 Interim / Quarterly Report Q4 2023	2024-02-28	English
Nykode Therapeutics - Quarterly report Q4 2023 Report Publication Announcement Q4 2023	2024-02-28	English
Nykode Therapeutics – invitation to Q4 2023 financial results presentation Report Publication Announcement	2024-02-22	English
Nykode Therapeutics – invitation to Q4 2023 financial results presentation Report Publication Announcement	2024-02-22	English